Eudaimonia Partners’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-23,500
| Closed | -$44.2K | – | 271 |
|
|
2023
Q3 | $44.2K | Hold |
23,500
| – | – | 0.01% | 322 |
|
|
2023
Q2 | $84.4K | Buy |
23,500
+3,500
| +18% | +$12.6K | 0.02% | 340 |
|
|
2023
Q1 | $67.4K | Hold |
20,000
| – | – | 0.02% | 339 |
|
|
2022
Q4 | $31K | Buy |
20,000
+9,000
| +82% | +$14K | 0.01% | 340 |
|
|
2022
Q3 | $15K | Hold |
11,000
| – | – | ﹤0.01% | 338 |
|
|
2022
Q2 | $24K | Buy |
+11,000
| New | +$24K | ﹤0.01% | 383 |
|
|
2021
Q2 | – | Sell |
-4,000
| Closed | -$35K | – | 578 |
|
|
2021
Q1 | $35K | Sell |
4,000
-3,000
| -43% | -$26.3K | 0.01% | 751 |
|
|
2020
Q4 | $56K | Hold |
7,000
| – | – | 0.01% | 571 |
|
|
2020
Q3 | $56K | Hold |
7,000
| – | – | 0.01% | 532 |
|
|
2020
Q2 | $69K | Hold |
7,000
| – | – | 0.03% | 424 |
|
|
2020
Q1 | $54K | Buy |
+7,000
| New | +$54K | 0.02% | 441 |
|